Parallel to upregulation of core histones, the CD177 gene (a neutrophil-specific marker), MYBL2 and RRM2 were highly expressed during the active phase of infection (0 weeks) and the expressed genes were reduced at 8 weeks after therapy. Here, RRM2 is linked to infection.